A Turkish study came to a similar conclusion that patients with NAFLD correlate with higher serum levels of C3 and acylation stimulating protein (ASP), the desarginated form of C3a (C3adesArg). This evidence concerns the gene C3 and metabolic dysfunction-associated steatotic liver disease.